TMCnet News
Genetesis Announces Two Abstracts Selected for Presentations at Upcoming Scientific MeetingsGenetesis, a market leading biomagnetic imaging company, has announced that recent data collected in clinical study with the company's lead product, CardioFlux was selected for abstract presentations at this year's American College of Emergency Physicians (ACEP) Scientific Assembly later this month and at American Heart Association (AHA) Scientific Sessions in November. These presentations will discuss the utility and improvements to standard of care when using CardioFlux as a diagnostic imaging solution to detect myocardial ischemia and diagnose coronary artery disease. The CardioFlux Magnetocardiograph has been designated a FDA Breakthrough Device for its potential benefits in improving and optimizing care in the triage process.
American College of Emergency Physicians (ACEP) Research Forum:
Presenter: Sharon Mace, MD, FACEP, FAAP, Principal Investigator of ACCMED, Emergency Medicine Physician at Cleveland Clinic Abstract #: 1145
American Heart Association (AHA) Scientific Sessions:
About Genetesis
View source version on businesswire.com: https://www.businesswire.com/news/home/20211019005066/en/ |